Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

18.50
-1.7700-8.73%
Pre-market: 18.620.1200+0.65%05:09 EDT
Volume:3.78M
Turnover:70.82M
Market Cap:1.78B
PE:-3.17
High:19.40
Open:19.36
Low:18.29
Close:20.27
52wk High:42.37
52wk Low:18.29
Shares:96.48M
Float Shares:92.79M
Volume Ratio:1.60
T/O Rate:4.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.03%
PB:-22.31
PE(LYR):-3.17

Loading ...

Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 19, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 12, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report